• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受大血管手术患者的血小板活化、心肌缺血事件及术后对阿司匹林无反应

Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.

作者信息

Rajagopalan S, Ford I, Bachoo P, Hillis G S, Croal B, Greaves M, Brittenden J

机构信息

Vascular Unit, Aberdeen Royal Infirmary, Aberdeen, UK.

出版信息

J Thromb Haemost. 2007 Oct;5(10):2028-35. doi: 10.1111/j.1538-7836.2007.02694.x. Epub 2007 Jul 23.

DOI:10.1111/j.1538-7836.2007.02694.x
PMID:17650080
Abstract

OBJECTIVES

Myocardial ischemia is the leading cause of postoperative mortality and morbidity in patients undergoing major vascular surgery. Platelets have been implicated in the pathogenesis of acute thrombotic events. We hypothesized that platelet activity is increased following major vascular surgery and that this may predispose patients to myocardial ischemia.

METHODS

Platelet function in 136 patients undergoing elective surgery for subcritical limb ischemia or infrarenal abdominal aortic aneurysm repair was assessed by P-selectin expression and fibrinogen binding with and without adenosine diphosphate (ADP) stimulation, and aggregation mediated by thrombin receptor-activating peptide and arachidonic acid (AA). Cardiac troponin-I (cTnI) was performed.

RESULTS

P-selectin expression increased from days 1 to 3 after surgery [median increase from baseline on day 3: 53% (range: -28% to 212%, P < 0.01) for unstimulated and 12% (range: -9% to 45%, P < 0.01) for stimulated]. Fibrinogen binding increased in the immediate postoperative period [median increase from baseline: 34% (range: -46% to 155%, P < 0.05)] and decreased on postoperative day 3 (P < 0.05). ADP-stimulated fibrinogen binding increased on day1 (P < 0.05) and thereafter decreased. Platelet aggregation increased on days 1-5 (P < 0.05). Twenty-eight (21%) patients had a postoperative elevation (> 0.1 ng mL(-1)) of cTnI. They had significantly increased AA-stimulated platelet aggregation in the immediate postoperative period and on day 2 (P < 0.05), and non-response to aspirin (48% vs. 26%, P = 0.036).

CONCLUSIONS

This study has shown increased platelet activity and the existence of non-response to aspirin following major vascular surgery. Patients with elevated postoperative cTnI had significantly increased AA-mediated platelet aggregation and a higher incidence of non-response to aspirin compared with patients who did not.

摘要

目的

心肌缺血是接受大血管手术患者术后死亡和发病的主要原因。血小板与急性血栓形成事件的发病机制有关。我们假设大血管手术后血小板活性增加,这可能使患者易患心肌缺血。

方法

通过P-选择素表达、有无二磷酸腺苷(ADP)刺激时的纤维蛋白原结合以及凝血酶受体激活肽和花生四烯酸(AA)介导的聚集,评估136例因临界性肢体缺血或肾下腹主动脉瘤修复而接受择期手术患者的血小板功能。检测心肌肌钙蛋白I(cTnI)。

结果

术后第1天至第3天,P-选择素表达增加[第3天相对于基线的中位数增加:未刺激时为53%(范围:-28%至212%,P<0.01),刺激时为12%(范围:-9%至45%,P<0.01)]。术后即刻纤维蛋白原结合增加[相对于基线的中位数增加:34%(范围:-46%至155%,P<0.05)],术后第3天下降(P<0.05)。ADP刺激的纤维蛋白原结合在第1天增加(P<0.05),此后下降。血小板聚集在第1至5天增加(P<0.05)。28例(21%)患者术后cTnI升高(>0.1 ng/mL)。他们在术后即刻和第2天AA刺激的血小板聚集显著增加(P<0.05),对阿司匹林无反应(48%对26%,P=0.036)。

结论

本研究表明大血管手术后血小板活性增加且存在对阿司匹林无反应的情况。与未出现这种情况的患者相比,术后cTnI升高的患者AA介导的血小板聚集显著增加且对阿司匹林无反应的发生率更高。

相似文献

1
Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.接受大血管手术患者的血小板活化、心肌缺血事件及术后对阿司匹林无反应
J Thromb Haemost. 2007 Oct;5(10):2028-35. doi: 10.1111/j.1538-7836.2007.02694.x. Epub 2007 Jul 23.
2
Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) study.血管手术患者术后心肌损伤与血小板反应性:大血管手术后血小板反应性与术后心肌损伤(PROMISE)研究
Thromb Res. 2022 Oct;218:177-185. doi: 10.1016/j.thromres.2022.08.023. Epub 2022 Aug 28.
3
Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.血小板活化程度随外周动脉疾病严重程度的增加而升高:对临床管理的启示。
J Vasc Surg. 2007 Sep;46(3):485-90. doi: 10.1016/j.jvs.2007.05.039.
4
Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets.阿司匹林不影响通过流式细胞术检测纤维蛋白原与人类血小板的结合,也不影响人类血小板α颗粒或溶酶体的释放。
Clin Sci (Lond). 1994 Nov;87(5):575-80. doi: 10.1042/cs0870575.
5
Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.氯吡格雷治疗对阿司匹林治疗的稳定型冠状动脉疾病患者应激诱导的血小板活化及心肌缺血的影响。
Thromb Haemost. 2007 Dec;98(6):1316-22. doi: 10.1160/th07-05-0323.
6
Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.血小板P-选择素糖蛋白IIb-IIIa表达激活阈值的差异及其临床意义。
Thromb Res. 1999 Jul 15;95(2):75-82. doi: 10.1016/s0049-3848(99)00019-5.
7
Changes in platelet function with inflammation in patients undergoing vascular surgery.血管手术患者炎症时血小板功能的变化。
Platelets. 2019;30(2):190-198. doi: 10.1080/09537104.2017.1392498. Epub 2017 Dec 11.
8
Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.在动脉粥样硬化性血管疾病患者中,氯吡格雷而非阿司匹林可降低P-选择素的表达并减少血小板-白细胞聚集体的形成。
Clin Pharmacol Ther. 2003 Mar;73(3):232-41. doi: 10.1067/mcp.2003.13.
9
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.氯吡格雷联合阿托伐他汀在冠状动脉旁路移植术后比阿司匹林能更显著地抑制血小板活性:一项前瞻性随机研究。
Clin Appl Thromb Hemost. 2010 Apr;16(2):189-98. doi: 10.1177/1076029609344980. Epub 2009 Aug 23.
10
Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression.体内阿司匹林治疗后进行体外阿昔单抗治疗对血小板聚集、ATP释放及P-选择素表达具有相加作用。
Thromb Res. 2000 Dec 15;100(6):479-88. doi: 10.1016/s0049-3848(00)00361-3.

引用本文的文献

1
Effects of intraoperative non-steroidal anti-inflammatory drugs on early postoperative pulmonary complications following lung resection: a retrospective propensity score-matched study.术中非甾体类抗炎药对肺切除术后早期肺部并发症的影响:一项回顾性倾向评分匹配研究
J Thorac Dis. 2025 May 30;17(5):3004-3014. doi: 10.21037/jtd-2024-2007. Epub 2025 May 28.
2
The Perioperative Management of Antiplatelet and Anticoagulant Drugs in Hip Fractures: Do the Surgery as Early as Possible.髋部骨折围手术期抗血小板和抗凝药物的管理:尽早进行手术。
Arch Bone Jt Surg. 2022 Jun;10(6):490-500. doi: 10.22038/ABJS.2021.56396.2800.
3
Efficacy and safety of a bridging strategy that uses intravenous platelet glycoprotein receptor inhibitors for patients undergoing surgery after coronary stent implantation: a meta-analysis.
经皮冠状动脉介入治疗术后桥接治疗策略中应用静脉内血小板糖蛋白Ⅱb/Ⅲa 受体抑制剂的疗效及安全性的荟萃分析。
BMC Cardiovasc Disord. 2022 Mar 24;22(1):125. doi: 10.1186/s12872-022-02563-3.
4
Targeting Platelet Activation in Abdominal Aortic Aneurysm: Current Knowledge and Perspectives.靶向治疗腹主动脉瘤中的血小板激活:当前的认识和展望。
Biomolecules. 2022 Jan 25;12(2):206. doi: 10.3390/biom12020206.
5
Perioperative changes of response to antiplatelet medication in vascular surgery patients.血管外科患者围手术期对抗血小板药物反应的变化。
PLoS One. 2020 Dec 29;15(12):e0244330. doi: 10.1371/journal.pone.0244330. eCollection 2020.
6
Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease.血小板衍生的 MRP-14 诱导有症状外周动脉疾病患者的单核细胞活化。
J Am Coll Cardiol. 2018 Jan 2;71(1):53-65. doi: 10.1016/j.jacc.2017.10.072.
7
[Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].[血管外科中乙酰水杨酸(ASA)低反应的患病率]
Chirurg. 2016 May;87(5):446-54. doi: 10.1007/s00104-016-0168-3.
8
Platelet activation increases in patients undergoing vascular surgery.接受血管手术的患者血小板活化增加。
Thromb Res. 2014 Nov;134(5):952-6. doi: 10.1016/j.thromres.2014.08.009. Epub 2014 Aug 23.
9
Patients who require non-cardiac surgery in acute coronary syndrome.急性冠状动脉综合征患者需要进行非心脏手术。
Curr Cardiol Rep. 2013 Jul;15(7):373. doi: 10.1007/s11886-013-0373-3.